Novo Nordisk Sues USPTO Over AERx Applications
Disgruntled after the U.S. Patent and Trademark Office rejected numerous applications for patents relating to its insulin delivery system, Danish pharmaceutical giant Novo Nordisk AS has sued the director of the...To view the full article, register now.
Already a subscriber? Click here to view full article